WHC is still in active development. Read this to understand our approach.
depiction of ZULJGOSFKWFVRX-UHFFFAOYSA-N.svg
tripsit

pramiracetam

Verificar en tripsit

psychonaut

Pramiracetam

Verificar en psychonaut

isomerdesign

Pramiracetam

Verificar en isomerdesign

druglab

Pramiracétam

Verificar en druglab

drugmap

Pramiracetam

Verificar en drugmap

wiki

Pramiracetam

Verificar en wiki

Data

InChI: InChI=1S/C14H27N3O2/c1-11(2)17(12(3)4)9-7-15-13(18)10-16-8-5-6-14(16)19/h11-12H,5-10H2,1-4H3,(H,15,18)

Sinónimos: N-(2-(diisopropylamino)ethyl)-2-(2-oxopyrrolidin-1-yl)acetamide,HS-0092,Amacetam,CHEMBL159776,Z221101674, Pramiracetam hydrochloride,68497-62-1,SCHEMBL195465,AB01566859_01, Ectapram,MLS006010035,N-{2-[bis(propan-2-yl)amino]ethyl}-2-(2-oxopyrrolidin-1-yl)acetamide,N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide,NCGC00346668-04,CI-879 FREE BASE,PRAMIRACETAM [WHO-DD],DB13247,Q415746,UNII-4449F8I3LE,NCGC00346668-01,A836161,Benzoic acid, o-(p-toluyl)-,ZINC1856108,Pramiracetam (INN),DTXSID60218604,N-(2-(bis(1-methylethyl)amino)ethyl)-2-oxo-1-pyrrolidineacetamide,Pramiracetamum [INN-Latin],SW219170-1,4449F8I3LE,pramiracetam,CS-1573,N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide,HMS3884N10,SMR004701212,P2061,N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxidanylidenepyrrolidin-1-yl)ethanamide,AKOS005066359,EN300-6492985, Neupramir,D08405,1-Pyrrolidineacetamide, N-(2-(bis(1-methylethyl)amino)ethyl)-2-oxo-,Q-201610,AC-8798,497P621,PRAMIRACETAM [MI],FT-0630777,C76170,CHEBI:135110, Amacetam hydrochloride,BCP27900,N-[2-(Diisopropylamino)ethyl]-2-oxopyrrolidin-1-acetamide,Pramiracetamum,Amacetam, N-[2-(Diisopropylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide,Pramiracetam [INN],N-[2-[Bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide, Vinpotropil,N-(2-(DIISOPROPYLAMINO)ETHYL)-2-OXO-1-PYRROLIDINEACETAMIDE,N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxo-1-pyrrolidinyl)acetamide, Pramiracetam sulfate,HMS3656M20, CNS-1879,CCG-267142,1-Pyrrolidineacetamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo-,HY-17455,Pramistar,s2594,DB-055157,Pramiracetam/CI-879,Pramiracetam, Amacetam sulfate, Remen

Estimated data

Solubilidad: -1.211 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 45.2% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.